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Abstract
Background: Recurrent otitis media is a common problem in young children. Echinacea and
osteopathic manipulative treatment have been proposed as preventive measures, but have been
inadequately studied. This study was designed to assess the efficacy of Echinacea purpurea and/or
osteopathic manipulative treatment (OMT) for prevention of acute otitis media in otitis-prone
children.
Methods: A randomized, placebo-controlled, two-by-two factorial trial with 6-month follow-up,
conducted 1999 – 2002 in Tucson, Arizona. Patients were aged 12–60 months with recurrent otitis
media, defined as three or more separate episodes of acute otitis media within six months, or at
least four episodes in one year. Ninety children (44% white non-Hispanic, 39% Hispanic, 57% male)
were enrolled, of which 84 had follow-up for at least 3 months. Children were randomly assigned
to one of four protocol groups: double placebo, echinacea plus sham OMT, true OMT (including
cranial manipulation) plus placebo echinacea, or true echinacea plus OMT. An alcohol extract of
Echinacea purpurea roots and seeds (or placebo) was administered for 10 days at the first sign of
each common cold. Five OMT visits (or sham treatments) were offered over 3 months.
Results: No interaction was found between echinacea and OMT. Echinacea was associated with a
borderline increased risk of having at least one episode of acute otitis media during 6-month follow-
up compared to placebo (65% versus 41%; relative risk, 1.59, 95% CI 1.04, 2.42). OMT did not
significantly affect risk compared to sham (44% versus 61%; relative risk, 0.72, 95% CI 0.48, 1.10).
Conclusion: In otitis-prone young children, treating colds with this form of echinacea does not
decrease the risk of acute otitis media, and may in fact increase risk. A regimen of up to five
osteopathic manipulative treatments does not significantly decrease the risk of acute otitis media.
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Background
By age 3 years, most children (50–84%) experience at
least one episode of acute otitis media (AOM). Recurrent
otitis media is also common; 10% to 19% of children suf-
fer 3 or more episodes during the first year alone [1]. In
children with recurrent otitis media, conventional
approaches to decreasing the risk of further episodes
include prophylactic antibiotic therapy and surgical inser-
tion of tympanostomy tubes to prevent accumulation of
middle ear effusion. The effectiveness of these approaches
is limited and controversial [2,3].
Complementary and alternative medicine (CAM) use in
pediatric patients remains relatively common. One survey
of parents at an urban pediatric emergency department
reported an overall incidence of CAM use of 15%. Herbal
remedies were used by 40% of those families that reported
use of CAM modalities[4]. CAM approaches are often
used for treatment of recurrent otitis media. A survey of
pediatric clinic patients in Quebec revealed that ear, nose,
and throat problems accounted for 24% of child visits to
alternative medicine practitioners [5], and a survey of par-
ents at a British pediatric otolaryngology clinic found that
29% reported CAM use, with echinacea and manipulative
treatments frequently cited [6].
A recent report suggested a benefit of osteopathic manip-
ulative treatment (OMT) in reducing episodes of AOM in
otitis-prone children [7]. The osteopathic concept of
recurrent otitis media postulates that predisposing struc-
tural dysfunction contributes to Eustachian tube dysfunc-
tion and is amenable to treatment with OMT, particularly
in the cranial region [8-11].
Echinacea is an herb commonly used for treatment of
upper respiratory tract infections. In vitro studies suggest
a stimulatory effect of Echinacea purpurea preparations on
various components of the immune system [12-14]. Sev-
eral studies demonstrate improvement in the severity and
duration of the common cold in adults treated with echi-
nacea products [15]. Others, including the most rigorous
study in children, show no benefit [16,17]. Because most
episodes of AOM follow upper respiratory tract infections,
it is plausible that treatment of such infections with echi-
nacea might decrease the risk of subsequent AOM.
We conducted a randomized, double-blind, placebo con-
trolled trial between 1999 – 2002 to assess the efficacy of
echinacea treatment (at the time of upper respiratory
infections) and OMT for the prevention of AOM in chil-
dren with recurrent otitis media.
Methods
Definitions
No generally accepted diagnostic definition for AOM
existed at the time of our study[18]. We defined AOM as
an acute illness with at least one symptom (fever, rhinor-
rhea, cough, otalgia, irritability, lethargy, anorexia, vomit-
ing, or diarrhea) and at least two otoscopic findings of
middle-ear inflammation (injection, opacity, fullness, or
impaired mobility) or purulent otorrhea. This definition
is consistent with the later 2004 American Academy of
Pediatrics guidelines on otitis media[19]. Recurrent otitis
media was defined as at least 3 separate episodes of AOM
within a 6-month period, or 4 episodes in one year. In
order for episodes to be considered separate, the protocol
required otoscopic documentation of resolution of one
episode, or at least two weeks without symptoms follow-
ing completion of antibiotic therapy, prior to onset of the
subsequent episode.
Subjects
Children aged 12–60 months with recurrent otitis media
(as documented in their medical records) were recruited
from the Arizona Health Sciences Center Pediatric Clinic
and from private pediatric offices in Tucson, Arizona.
Children were excluded for unwillingness to participate,
congenital malformations of the ears, nose, or throat (e.g.,
cleft palate), known or suspected allergy to echinacea,
immune deficiency including HIV infection, or tuberculo-
sis. Children taking prophylactic antibiotics or who had
tympanostomy tubes in place were excluded from enroll-
ment. The Arizona Health Sciences Center Pediatric Clinic
serves an urban population, of which approximately 75%
are covered by Medicaid.
Randomization
Randomization was done in blocks of eight using a ran-
dom number table by a clinical pharmacist (KLG) having
no contact with participants. Children were randomly
assigned to one of four groups in a two-by-two factorial
design. The first group received placebo extract orally and
sham manipulation. The second group received Echinacea
purpurea extract and sham manipulation. The third group
received placebo extract and true OMT. The last group
received Echinacea purpurea extract and true OMT. Sequen-
tially numbered, indistinguishable bottles of echinacea or
placebo were provided in advance. After informed con-
sent was obtained, the parent was given the next bottle in
sequence, and the pharmacist was telephoned to deter-
mine which of two osteopathic physicians was assigned
(also determined randomly). The osteopathic physician
independently contacted the pharmacist to learn whether
a child was to receive sham or true osteopathic manipula-
tive treatment. Children, families, and pediatricians were
blinded to the group assignment of each subject.BMC Complementary and Alternative Medicine 2008, 8:56 http://www.biomedcentral.com/1472-6882/8/56
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Interventions
Children assigned to echinacea treatment received a 1:1
weight-to-volume 50% ethanol liquid extract of the fresh
roots and dried mature seeds of Echinacea purpurea manu-
factured by Eclectic Institute, Inc. (Sandy, Oregon). All
echinacea came from the same lot number, with an anal-
ysis by the manufacturer confirming 50% root and seed
extract of Echinacea purpurea. A similar, identically labeled
placebo prepared by Eclectic Institute contained 50% eth-
anol, 45% filtered water, food coloring and thickeners.
Parents were instructed to give 0.5 ml orally 3 times daily
for 3 days at the onset of cold symptoms, followed by 0.25
ml orally 3 times daily for 7 more days.
All children were scheduled for osteopathic sessions as
soon as possible after entry, then 2, 4, 8, and 12 weeks
later. At each visit, children assigned to OMT received
diagnostic examinations and concurrent treatments as
deemed necessary by the treating physician. Treatment
modalities were limited to cranial osteopathy, balanced
membranous/ligamentous tension, and/or myofascial
release (applied directly or indirectly). These treatments
consist of gentle manipulations of the cranium, pelvis,
diaphragm, and other structures. No high velocity or
thrusting maneuvers were performed. At the discretion of
the osteopathic physician, an osteopathic percussion
hammer could also be used for treatment, which allowed
gentle vibration in tissues at variable frequencies. Chil-
dren assigned to sham manipulation received an osteo-
pathic examination only (palpation of the cranial bones
and muscles and other structures) without treatment
maneuvers.
The osteopathic physicians were well-respected members
of the Tucson osteopathic community with practices
restricted to manipulative treatment. All were members of
the American Academy of Osteopathy and the Cranial
Academy.
In addition to the study interventions, all parents received
educational materials regarding otitis risk factors. If after
enrollment a child received prophylactic antibiotics,
otolaryngology referral, or tympanostomy tubes (usually
for further recurrences of AOM), this information was
recorded, but the child was allowed to remain in the
study. Such decisions were made on clinical grounds by
the treating clinician and were not influenced by the
child's participation in the study.
Follow-up
After enrollment, children were prospectively followed for
6 months, with monthly telephone contact, and availabil-
ity for evaluation 5 days per week by study pediatricians
(MBA and RAW) if AOM was suspected. Children diag-
nosed with ear infection during weekends were asked to
see one of the study physicians early the following week
to confirm the diagnosis. In addition, children received
otoscopic and physical examinations at entry, at 3
months, and at 6 months by study pediatricians, who
were blinded to the treatment assignment of subjects.
Data collection
At enrollment, a questionnaire was used to collect infor-
mation about the child's previous episodes of AOM, past
medical history, cigarette smoke exposure, previous use of
study alternative interventions, family history of allergy,
and recurrent otitis media. The results of otoscopic and
physical examinations were recorded at entry, 3, and 6
months, and at the time of any evaluation for possible
AOM. At monthly telephone contacts, parents were asked
if the child had any suspected or diagnosed ear problems
during the previous month, and whether any side effects
of the interventions were suspected. Parents were also
asked at the 3- and 6-month visits whether they believed
their child was receiving placebo for each study interven-
tion.
Main outcome measures
The primary study outcome was the occurrence of a first
episode of AOM during the study period as defined above.
The final analysis was performed using only episodes of
AOM that were sufficiently well documented in the med-
ical record to meet the definition as described in the
paper. A secondary outcome was the number of episodes
of AOM. For this secondary outcome measure, all physi-
cian-diagnosed episodes of AOM were included, without
respect to the case definition for AOM.
Analysis
Children were analyzed in the groups into which they
were randomized. An initial analysis was done to deter-
mine if there was any important interaction between the
effects of echinacea and OMT on the occurrence of AOM.
Since none was found, the two interventions were consid-
ered independently. For each intervention, the cumulative
incidence of AOM during follow-up was compared
between treatment and placebo groups using chi-square
analysis and the relative risk (RR) with 95% confidence
interval (CI). P was considered significant at P < 0.05. The
time to first episode of AOM was compared between
groups using Kaplan-Meier analysis and the log rank test.
Kaplan-Meier curves were truncated at 200 days of follow-
up. Cox regression was used to estimate the relative risk of
AOM during follow-up with adjustment for confounding
effects of other factors. The median number of episodes of
AOM during follow-up was compared using the Mann-
Whitney nonparametric test. Analyses were performed
using SPSS for Windows (Version 11.5.0, SPSS Inc., Chi-
cago, IL) and EpiInfo (Version 5.01b, CDC and USD, Inc.,
Stone Mountain, GA).BMC Complementary and Alternative Medicine 2008, 8:56 http://www.biomedcentral.com/1472-6882/8/56
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Sample size
We assumed the risk of having at least one episode of
AOM during 6 months of observation among children
with recurrent otitis media to be 60%. With no effect
modification between echinacea and osteopathic treat-
ment, a final sample of 100 children (50 subjects per
group for each analysis), was needed to provide 80%
power to detect a 50% reduction in the risk of AOM asso-
ciated with the treatment being analyzed (alpha = 0.05).
This magnitude of risk reduction is comparable to that
observed with antibiotic prophylaxis [20].
The study was conducted with the approval of the Univer-
sity of Arizona Human Subjects Committee, and
informed consent was obtained from a parent or guardian
of each subject.
Results
Ninety children were enrolled in the study, 74 from the
university-based clinic and 16 from private practice sites.
Subjects had a median age of 1.5 years. The majority was
male (57%) and white non-Hispanic (44%) or Hispanic
(39%). Despite randomization, there were notable differ-
ences among treatment groups in the frequency of poten-
tially confounding factors, especially gender, presence of
siblings in the home, frequency of AOM prior to study
entry, and daycare attendance (Table 1).
Six subjects (7%) withdrew or were lost to follow-up
within 3 months of enrollment (1–2 in each group). Only
19% of subjects attended all 5 scheduled osteopathic vis-
its, but 64% had 3 or more treatment visits (see CON-
SORT diagram [21]: Additional file 1). The percentage of
subjects that came for follow-up examinations was 69% at
3 months and 62% at 6 months. Medical record informa-
tion on the occurrence of AOM during at least 3 months
of follow-up was available for 84 subjects (93%). The
length of follow-up ranged from 2 to 278 days (median
183).
Of 84 children followed for 3 months or more, 44 (52%)
had one or more episodes of AOM as defined above. The
cumulative incidence of AOM varied from 39% to 80%
among the treatment groups (P = 0.04) (Figure 1). The
highest rate of AOM was among children receiving echi-
nacea alone.
The pattern of variation in incidence rates among the
treatment groups did not suggest any plausible effect
modification between echinacea treatment and OMT on
the risk of AOM (Figure 1). In addition, a likelihood ratio
test for interaction between the two treatments using Cox
regression was not significant (P = 0.40). Therefore, the
independent effects of echinacea and OMT were assessed
separately.
The use of echinacea was associated with an increased risk
of AOM of borderline statistical significance. Sixty-five
percent of children assigned to echinacea experienced
AOM compared to 41% of children taking placebo (RR
1.59, 95% CI 1.04, 2.42). The Kaplan-Meier analysis using
all 90 subjects yielded nearly identical results (Figure 2).
OMT was not significantly associated with the risk of
AOM. Forty-four percent of children receiving OMT expe-
rienced AOM compared to 61% of children undergoing
Table 1: Subject characteristics according to assigned treatment group
Randomized Treatment Group
Sham Manipulation Real Manipulation
Placebo Echinacea Real Echinacea Placebo Echinacea Real Echinacea Total Sample
Characteristic % % % % %
Age, years (median ± SD) 1.5 ± 0.9 1.5 ± 0.5 1.6 ± 0.5 1.6 ± 0.7 1.5 ± 0.7
Ethnicity
White, non Hispanic 45% 41% 42% 50% 44%
Hispanic 41 41 38 36 39
Native American 9 14 4 - 7
Black, non Hispanic 5 5 4 9 6
Asian - - 8 5 3
Other - - 4 - 1
Male gender 68 59 50 50 57
Breastfed ≥ 6  m o . 2 72 32 93 2 2 8
Sibling(s) in home 64 68 54 50 59
AOM ≥ 5× in past year 32 64 30 23 37
D a y c a r e  a t t e n d a n c e 4 16 45 86 4 5 7
Cigarette smoke exposure 23 18 25 14 20
Total number in group N = 22 N = 22 N = 24 N = 22 N = 90BMC Complementary and Alternative Medicine 2008, 8:56 http://www.biomedcentral.com/1472-6882/8/56
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sham treatment (RR 0.72, 95% CI 0.48, 1.10). Restriction
of the analysis to 56 children who had 3 or more osteo-
pathic treatment visits did not change the findings (RR
0.70, 95% CI 0.41, 1.19). Results of Kaplan-Meier analysis
using all 90 children were similar (Figure 3).
We estimated the effects of echinacea and OMT on the risk
of AOM after adjustment for confounding factors using
Cox regression in all 90 subjects (Table 2). The adjusted
relative risk of AOM for echinacea treatment was 1.73
(95% CI 0.94, 3.18). The adjusted relative risk for OMT
was 0.84 (95% CI 0.44, 1.61). Four variables (younger
age, male gender, Hispanic ethnicity, and presence of one
or more siblings at home) were independently associated
with the risk of AOM and were included in the regression
model.
There was no significant difference in the median number
of episodes of AOM during the study period between
treatment and placebo groups for either echinacea or
OMT. Comparisons were made using the Mann-Whitney
nonparametric test.
One subject withdrew from the study following an
adverse effect (vomiting after taking the echinacea pla-
cebo). One additional subject reported adverse effects
(vomiting and non-urticarial rash two days after starting
echinacea for a viral upper respiratory illness) but did not
withdraw. Neither adverse effect was considered to have
been caused by the study medication. As reported in
monthly telephone interviews and at the 3- and 6-month
visits, there was no statistically significant difference in
reporting of any side effects between placebo and treat-
ment groups for either echinacea or OMT.
Parents were unable to distinguish whether their child was
receiving echinacea treatment or placebo. However, when
asked about OMT after 3 months, parents of children
assigned to OMT were significantly more likely to believe
their child was receiving actual OMT than parents of chil-
dren assigned to sham (Figure 4). Even so, only 20% of
parents of children assigned to sham treatments believed
their child to be receiving placebo. Interestingly, the abil-
ity to distinguish OMT from sham treatment disappeared
entirely by 6 months.
Cumulative incidence of AOM according to assigned treatment group Figure 1
Cumulative incidence of AOM according to assigned treatment group. The P value is for at least one group being 
significantly different from the others.BMC Complementary and Alternative Medicine 2008, 8:56 http://www.biomedcentral.com/1472-6882/8/56
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Discussion
We found that preventive treatment with osteopathic
manipulation did not result in a statistically significant
decrease in the risk of AOM in otitis-prone children. Treat-
ment with an alcohol extract of Echinacea purpurea root
and seeds at times of upper respiratory infection was asso-
ciated with a modestly increased risk of AOM. This effect
was of borderline statistical significance and may have
been due to chance.
As noted, the randomization process resulted in an une-
qual distribution of certain otitis risk factors among treat-
ment groups. The group receiving echinacea alone
appeared to be at higher risk based on several factors, and
this chance occurrence may have been responsible for the
higher rate of otitis in the echinacea group. We adjusted
for known confounding factors, resulting in modest
changes in relative risk estimates, but the possibility of
incomplete adjustment, or unmeasured confounding by
other factors cannot be excluded.
This is the first randomized, placebo-controlled trial of
Echinacea purpurea for the prevention of AOM. We chose
to treat children at the time of upper respiratory tract
infections, rather than using a prolonged preventive regi-
men, based on the finding that echinacea appeared to be
more effective in treatment than prevention of URI in
adults [22]. Two subsequent randomized trials did not
confirm this pattern in children. Taylor and colleagues
found the pressed juice of E. purpurea aerial plant to be of
no benefit to children in treatment of the common cold
[16]. Cohen reported a significant reduction in colds and
other respiratory outcomes following preventive use of a
product containing liquid extracts of E. purpurea aerial
plant, E. angustifolia root, propolis, and vitamin C [23].
The latter study also showed a decreased risk of acute otitis
media with the echinacea product, but was not designed
to measure this outcome in a rigorous way. Recent studies
have confirmed our premise that AOM in children is a fre-
quent complication of viral upper respiratory tract infec-
tion [24,25].
Kaplan-Meier estimates of the probability of AOM according to treatment with echinacea or placebo Figure 2
Kaplan-Meier estimates of the probability of AOM according to treatment with echinacea or placebo.
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Research on the therapeutic use of echinacea is compli-
cated by the fact that there are three species of echinacea
in common use, and preparations are made from various
combinations of leaves, flowers, roots, and seeds of the
plant. Furthermore, various methods of preparation are
used, including alcohol or glycerin extraction, desiccation,
and juicing. These issues are discussed elsewhere with
respect to the present study [26]. Our results cannot be
generalized to other forms of echinacea.
One previous study evaluated OMT for prevention of
AOM in otitis-prone children [7]. The authors reported a
statistically significant decreased frequency of AOM epi-
sodes and fewer surgical episodes among treated children.
That protocol called for 9 osteopathic treatment visits,
compared with 5 in the present study. As noted by the
authors, that study did not have a placebo control, and the
control group had a very high dropout rate, a combina-
Kaplan-Meier estimates of the probability of AOM according to treatment with osteopathic manipulative treatment (OMT) or  sham Figure 3
Kaplan-Meier estimates of the probability of AOM according to treatment with osteopathic manipulative 
treatment (OMT) or sham.
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Table 2: Cox regression estimates of the effect of echinacea and osteopathic manipulative treatment on the risk of AOM after 
adjustment for other factors
Relative Risk 95% Confidence
Variable Interval P-value
Echinacea treatment 1.73 0.94, 3.18 0.08
Osteopathic manipulative treatment 0.84 0.44, 1.61 0.60
Age (y) 0.49 0.26, 0.89 0.02
Male gender 2.15 1.09, 4.21 0.03
Hispanic ethnicity 2.02 1.10, 3.72 0.02
Siblings in home (1 or more vs. none) 1.96 0.99, 3.89 0.05BMC Complementary and Alternative Medicine 2008, 8:56 http://www.biomedcentral.com/1472-6882/8/56
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tion of factors with a significant potential to introduce
bias.
The main limitations of this study were small sample size
and incomplete compliance with osteopathic treatments
and follow-up visits. Our final analysis involved 84 sub-
jects, yielding 73% power to detect a 50% risk reduction
under our initial assumptions. The borderline increased
risk associated with echinacea treatment make a protective
effect of this form and dosage schedule of echinacea very
unlikely, despite the sample size.
Because we were able to identify episodes of AOM
through medical record review, the incomplete compli-
ance with follow-up pediatrician visits had limited impact
on our findings. However, it is possible that the lack of a
statistically significant benefit found for OMT was the
result of inadequate compliance with OMT visits. An anal-
ysis restricted to subjects attending 3 or more treatment
visits did not suggest a greater protective effect of OMT,
but the sample size was small. On the other hand,
research personnel exerted considerable effort at getting
subjects to these visits, with limited success, perhaps
because the children were not ill at those times. An analy-
sis of the reasons for limited participation by families with
OMT may be useful for future OMT research.
An ancillary purpose of this study was to determine if a
suitable sham for osteopathic manipulation could be
devised. A previous study of sham chiropractic treatment
in children did not evaluate how parents perceived the
sham treatment[27]. We hoped to be able to show that
parents would be unable to distinguish examination
alone from examination and concurrent treatment. In
fact, about 20% of parents of sham recipients (versus 4%
in the true treatment group) correctly thought that the
child was receiving sham manipulation. However, the
large majority of parents of sham recipients could not tell
that the "sham manipulation" was placebo. Some osteo-
pathic physicians believe any "hands-on" contact has
potential therapeutic benefit. To the extent this is true, our
"sham" treatment could mask an actual benefit of OMT.
Conclusion
Treatment of upper respiratory infections in otitis-prone
children with an alcohol extract of the roots and seeds of
Echinacea purpurea does not decrease the risk of AOM, and
may in fact increase risk. In the same population of chil-
dren, a preventive regimen of from one to five osteopathic
manipulative treatments over three months did not signif-
icantly decrease their risk of acute otitis media.
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